Source: Frenkel Benefits Blog

Frenkel Benefits Blog The Answer for Gene Therapy Costs?

The last decade has ushered in exploding prescription drug costs with the proliferation of specialty drugs. My colleague, Craig Hasday, blogged about controlling these health plan costs last week. And although many of those drugs placed a major dent in our client’s healthcare plans, the next batch of specialty meds – gene therapy drugs –... [Read More]

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Craig Hasday's photo - CEO of Frenkel Benefits

CEO

Craig Hasday

CEO Approval Rating

64/100

Read more